Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 


BCRP inhibitor
BML-EI396-0005 5 mg 179.00 USD
BML-EI396-0025 25 mg 776.00 USD
Do you need bulk/larger quantities?
Analog of the fungal toxin fumitremorgin C (Prod. No. ALX-350-127). Potent and selective inhibitor of the breast cancer resistance protein multidrug transporter (BCRP, EC90=26nM). Highly effective for increasing the intracellular drug accumulation and reversing BCRP-mediated multidrug resistance yet has little activity against P-glycoprotein, multidrug resistance-associated protein (MRP1) and other known drug transporters. In mouse models Ko143 was able to restore the intracellular accumulation and abolish the directionality in net flux of dasatinib. It is a highly useful tool for the identification of drug transport processes in complex experimental systems.

Product Details

Alternative Name:(3S,6S,12aS)-1,2,3,4,6,7,12,12a-Octahydro-9-methoxy-6-(2-methylpropyl)-1,4-dioxopyrazino-[1',2':1,6]pyrido[3,4-b]indole-3-propanoic acid 1,1-dimethylethyl ester
Purity:≥96% (HPLC)
Appearance:White solid.
Solubility:Soluble in DMSO (>25mg/ml) or 100% ethanol (>25mg/ml).
Shipping:Ambient Temperature
Long Term Storage:-20°C
Use/Stability:Store solutions at -20°C for up to 3 months.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia: S. Sucha, et al.; Biomed. Pharmacother. 150, 112962 (2022), Abstract;
Folium Sennae Increased the Bioavailability of Methotrexate through Modulation on MRP 2 and BCRP: C.P. Yu, et al.; Pharmaceuticals 14, 1036 (2021), Abstract;
Increased Systemic Exposure of Methotrexate by a Polyphenol-Rich Herb via Modulation on Efflux Transporters Multidrug Resistance-Associated Protein 2 and Breast Cancer Resistance Protein: C.P. Yu, et al.; J. Pharm. Sci. 105, 343 (2016), Application(s): Positive inhibitor of BCRP, Abstract;
Dinaciclib, a cyclin-dependent kinase inhibitor, is a substrate of human ABCB1 and ABCG2 and an inhibitor of human ABCC1 in vitro: D. Cihalova, et al.; Biochem. Pharmacol. 98, 465 (2015), Application(s): MDCKII monolayer transport assay, Abstract;
Influence of drug transporters and stereoselectivity on the brain penetration of pioglitazone as a potential medicine against Alzheimer's disease: K.L. Chang, et al.; Sci. Rep. 5, 9000 (2015), Application(s): Cell Culture, Abstract; Full Text
ABC transporter activity linked to radiation resistance and molecular subtype in pediatric medulloblastoma: W.J. Ingram, et al.; Exp. Hematol. Oncol. 2, 26 (2013), Abstract; Full Text
Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs: P. Matsson, et al.; Pharm. Res. 26, 1816 (2009), Abstract;
P-glycoprotein and breast cancer resistance protein influence brain distribution of dasatinib: Y. Chen, et al.; J. Pharmacol. Exp. Ther. 330, 956 (2009), Abstract;
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C: J.D. Allen, et al.; Mol. Cancer Ther. 1, 417 (2002), Abstract;

Related Literature

Stem Cells
Stem Cells
Download as PDF

All new literature pieces